2BB score and signals
Lexeo Therapeutics, Inc.’s current 2BB score is 26 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 16 | Very Low |
| Momentum | 11 | Strongly Weakening |
| Financial strength | 11 | Very Weak |
| Quality | 80 | Very Strong |
| Risk | 41 | Moderate |
Company facts
| Founded | 2017 |
| Employees | 59 |
| 52-week range | $3.99 – $10.99 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-09 | — | -0.3343 | — | $0.00 |
| 2026-08-19 | — | -0.2907 | — | $0.00 |
| 2026-05-11 | -0.25 | -0.3196 | $0.00 | $0.00 |
| 2026-03-30 | -0.27 | -0.3208 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish